A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
Clinical trial NCT04682353 · COMPLETED
Trial details
- NCT number
- NCT04682353
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2022-07-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.